| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 925 | 925 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| OCATA THERAPEUTICS | 1,827 | |
| BANK OF AMERICA | 37,569 | |
| GENERAL ELECTRIC | 12,635 | |
| ADVANCED CELL TECHNOLOGY |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK CHARGES | 80 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX | 1,235 |